We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TXO:NYSETXO Partners, L.P. Analysis

Data as of 2026-05-06 - not real-time

$12.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

TXO Partners is trading at $12.37, well below its DCF‑derived fair value of $49.34, implying a **~70% upside** potential. The stock sits just above the 20‑day SMA (12.16) but below the 50‑day (12.44) and 200‑day (12.83) averages, confirming a **bearish longer‑term trend** despite a **bullish MACD histogram** (+0.05) and a neutral RSI (51). Volume is on the rise, supporting the recent **short‑term price bounce** toward the resistance level of $12.74. A **high dividend yield of 13.75%** and a modest payout ratio (5.6%) are attracting income‑focused investors, though the company’s negative free cash flow and -5.4% profit margin raise sustainability concerns. Recent news of a planned **$100 million asset sale** and a **quarterly distribution of $0.35 per unit** provide near‑term cash inflows that could shore up liquidity. However, the **30‑day volatility of 23.5%**, a **max drawdown of –42.6%**, and a **beta near zero** highlight significant price swings and limited market correlation. Analysts rate the stock as a “strong buy” with median price targets around $22, but the underlying fundamentals—negative earnings, high debt‑to‑equity (42x) and weak operating margins—suggest caution for longer horizons.
In summary, the technical setup and dividend appeal make TXO a compelling short‑term play, while the stark valuation gap and sector recovery prospects could justify a hold or cautious buy for medium‑term investors, albeit with heightened risk due to earnings volatility and regulatory headwinds.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 9/10

Key Factors

  • Bullish MACD histogram with increasing volume
  • Attractive 13.75% dividend yield
  • Asset sale expected to raise $100 million cash

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Significant valuation upside versus DCF fair value
  • Negative earnings and free cash flow risk
  • Analyst median price target around $22

Long Term

> 3 years
Positive
Model confidence: 6/10

Key Factors

  • Potential upside if cash flow turns positive
  • Long‑term commodity price recovery in the Permian and Williston basins
  • Low beta indicating limited market correlation

Key Metrics & Analysis

Financial Health

Revenue Growth41.00%
Profit Margin-5.39%
P/E Ratio13.5
ROE-3.32%
ROA-1.60%
Debt/Equity42.08
P/B Ratio1.0
Op. Cash Flow$118.2M
Free Cash Flow$-135335632
Industry P/E20.7

Technical Analysis

TrendBearish
RSI51.4
Support$11.31
Resistance$12.74
MA 20$12.16
MA 50$12.44
MA 200$12.83
MACDBullish
VolumeIncreasing
Fear & Greed Index90.38

Valuation

Fair Value$49.34
Target Price$21.00
Upside/Downside69.77%
GradeUndervalued
TypeValue
Dividend Yield13.75%

Risk Assessment

Beta0.01
Volatility23.51%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.